New Class of Drugs Could Revolutionize Cancer Treatment

PARP inhibitors show potential to transform understanding of cancer

By Rob Quinn, Newser Staff

Posted Jun 25, 2009 9:12 AM CDT

(Newser) – A new class of drugs in development represents the biggest cancer breakthrough in a decade, Robert Bazell writes at NBC. In a study causing much excitement in the medical world, breast, ovarian, and prostate cancer patients treated with Olaparib, one of a group of drugs... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

2 comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Miami Face-Eater Identified

'Serpent Pastor' Dies of Snake Bite

NBC News (Source Grid »)

Experimental pill beats inherited cancers
WebMD

Successful trial likely to lead to large-scale research
Daily Mail (UK)

Health

breast cancer • ovarian cancer • cancer treatment • cancer drug • olaparib • PARP inhibitors • women's issues

More Newser Stories

Why Cancer Researchers Are Playing it Safe

Long-shots are risky to fund, so grants go to less ambitious studies

(NEWSER) - If you're a cancer researcher, it's harder to get money to investigate a potentially field-changing question than to find out whether a food's tastiness affects dieting. The reason is simple but problematic: With limited funding available and lots of research to do, grant-givers don't want to lose money on a long shot, writes the New York Times. More»

Drug Offers Hope for Genetic Breast Cancer Sufferers

First-of-its-kind drug slows, stops tumor growth

(NEWSER) - A first-of-its-kind drug has been developed to fight genetic breast cancer, with an initial round of human trials showing “very promising” results, reports the Times of London. The drug Olaparib works by blocking a protein that makes cancer cells containing the genetic default unable to repair themselves. The drug shrank tumors or stopped their growth in 40% of cases studied. More»

Breast Cancer: Not One but 10 Diseases

Genetic study offers 'completely new way of looking at breast cancer'

(NEWSER) - Breast cancer isn't a single disease but an umbrella term for 10 genetically distinct diseases, according to the biggest-ever study of the genetics of breast tumors. The researchers, who split the disease into 10 categories after examining samples from 2,000 tumors, say the study offers a "completely new way of looking at breast cancer" that will allow much more precisely targeted therapies for sufferers in the future, the BBC reports. More»

In Case of 2 Cancer Drug Shortages, Relief

FDA OKs imports of doxorubicin, methotrexate substitutes

(NEWSER) - Though the FDA cautions that "we're not out of the woods," it today announced that dangerous shortages of two cancer drugs are being addressed. Stores of the drugs in question—doxorubicin and methotrexate—became dangerously low after the company that made them closed its Ohio manufacturing facility over product safety concerns. Lipodox, a drug out of India similar to doxorubicin, has been OKed for shipment and will be used in the treatment of ovarian cancer and multiple myeloma. More»

Drug Combos Hailed as Big Breast Cancer Breakthrough

New drug combos delay tumor growth in advanced cases

(NEWSER) - Two new studies mark what could be the biggest breakthrough in treating breast cancer in more than a decade, researchers say. Both involve combining drug therapies that attack tumors in different ways, significantly delaying the time until women with advanced breast cancer became sicker, the AP reports. One treatment held tumor growth at bay for around six months longer than conventional treatments; the other delayed it for four months longer. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

New Class of Drugs Could Revolutionize Cancer Treatment

PARP inhibitors show potential to transform understanding of cancer

breast cancer • ovarian cancer • cancer treatment • cancer drug • olaparib • PARP inhibitors • women's issues

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Why Cancer Researchers Are Playing it Safe

Long-shots are risky to fund, so grants go to less ambitious studies

Drug Offers Hope for Genetic Breast Cancer Sufferers

First-of-its-kind drug slows, stops tumor growth

Breast Cancer: Not One but 10 Diseases

Genetic study offers 'completely new way of looking at breast cancer'

In Case of 2 Cancer Drug Shortages, Relief

FDA OKs imports of doxorubicin, methotrexate substitutes

Drug Combos Hailed as Big Breast Cancer Breakthrough

New drug combos delay tumor growth in advanced cases

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?